Table 3. Prevalence of HLA-DQ2, HLA-DQ8, any HLA (either HLA-DQ2 or HLA-DQ8), and both HLA (HLA-DQ2 and HLA-DQ8) genotypes in patients with lipedema from our study and in the general population.

Percentages indicate the proportion of individuals within each group possessing the specific genotype. (p<0.0001, chi-squared=26.128, degrees of freedom=3, contingency coefficient=0.000337).

	Patients in our study with lipedema	General population
HLA-DQ2	47.37%	41.20%
HLA-DQ8	22.11%	11.30%
Any HLA (HLA-DQ2 or HLA-DQ8)	61.05%	53.70%
Both HLAs (HLA-DQ2 and HLA-DQ8)	7.37%	1.2%